Cochrane Abstracts
Interleukin‐1 inhibitors for acute gout
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interleukin‐1 Inhibitors for Acute Gout." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434027/all/Interleukin‐1_inhibitors_for_acute_gout.
Interleukin‐1 inhibitors for acute gout. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434027/all/Interleukin‐1_inhibitors_for_acute_gout. Accessed January 29, 2025.
Interleukin‐1 inhibitors for acute gout. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434027/all/Interleukin‐1_inhibitors_for_acute_gout
Interleukin‐1 Inhibitors for Acute Gout [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434027/all/Interleukin‐1_inhibitors_for_acute_gout.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interleukin‐1 inhibitors for acute gout
ID - 434027
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434027/all/Interleukin‐1_inhibitors_for_acute_gout
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
